Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,916 | -2,483 | -9,289 | -6,216 | -3,767 |
| Accounts payable and accrued liabilities | 14 | 53 | -23 | -5 | -9 |
| Other Working Capital | -328 | -574 | 663 | 248 | -333 |
| Other Operating Activity | 225 | 62 | 442 | 362 | 300 |
| Operating Cash Flow | $-5,005 | $-2,942 | $-8,207 | $-5,611 | $-3,809 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -481 | -481 | -12,173 | -11,224 | -6,642 |
| Sale Of Investment | 3,500 | 1,750 | 15,680 | 11,990 | 9,240 |
| Investing Cash Flow | $3,019 | $1,269 | $3,507 | $766 | $2,598 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 55 | 55 | 567 | 535 | N/A |
| Financing Cash Flow | $55 | $55 | $567 | $535 | $N/A |
| Exchange Rate Effect | -3 | -2 | 60 | 61 | 42 |
| Beginning Cash Position | 2,815 | 2,815 | 6,888 | 6,888 | 6,888 |
| End Cash Position | 881 | 1,195 | 2,815 | 2,639 | 5,719 |
| Net Cash Flow | $-1,934 | $-1,620 | $-4,073 | $-4,249 | $-1,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,005 | -2,942 | -8,207 | -5,611 | -3,809 |
| Free Cash Flow | -5,005 | -2,942 | -8,207 | -5,611 | -3,809 |